Disorder Of Pilosebaceous Unit C0554472
Conditions affecting hair follicles and oil glands, including acne and folliculitis. Treatment varies by type and severity.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Topical retinoid therapy
First-line pharmacological treatment for pilosebaceous unit disorders involving follicular hyperkeratinization. Topical retinoids normalize follicular epithelial turnover and reduce comedone formation.
Gentle skincare routine optimization
Implementation of non-comedogenic skincare products and gentle cleansing techniques to reduce follicular irritation and maintain skin barrier integrity.
Additional treatment options
Low-glycemic dietary modification
Dietary changes emphasizing low-glycemic index foods to reduce insulin-mediated androgen activity that stimulates sebaceous gland function.
dietaryLight and laser therapy
Targeted phototherapy using specific wavelengths to reduce sebaceous gland activity, decrease follicular inflammation, and modulate skin cell turnover.
physical_therapyAnti-androgen therapy
Systemic anti-androgen medications for severe or refractory cases where androgen-mediated sebaceous gland hyperactivity is a significant contributing factor.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Disorder Of Pilosebaceous Unit C0554472?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016.
Pochi PE, Shalita AR, Strauss JS, et al. Report of the consensus conference on acne classification. J Am Acad Dermatol. 1991.
Mazzurana L, Bonamonte D, Filoni A, et al. Efficacy of topical treatments for rosacea: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2022.
Fitzpatrick JE, High WA. Sebaceous gland disorders. In: Dermatology Secrets. 6th ed. Elsevier; 2021.
Medication Comparisons
Compare medications used to treat Disorder Of Pilosebaceous Unit C0554472. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy